BL
Bausch + Lomb
BLCO · NYSE
$18.07 -0.39% (-$0.07)
1M +7.19%
Market Cap $6.45B
P/E Ratio -
Div. Yield -
ROE 2.67%
Bulios Fair Price
$14.51
19.7% downside
Current Price
$18.07
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BLCO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
50 /100
Fair EV/EBITDA 15.10x
P/S 1.21x
P/B 1.01x
Growth
56 /100
Stable Rev. growth 10.62%
Book val. growth 2.85%
EPS growth N/A
Profitability
36 /100
Moderate Gross margin 57.23%
Net margin 3.21%
Op. margin 7.14%
Quality
22 /100
Poor ROIC 7.93%
ROE 2.67%
ROA 1.23%
Debt
32 /100
High Debt/Equity 0.80x
Current ratio 1.55x
Int. coverage 0.84x
Stability
53 /100
Moderate Beta 0.55x
Rev. volatility 4.58%
EPS volatility 1,043.55%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BLCO
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Brenton L. Saunders
Employees
13,000
Headquarters
Vaughan
Upcoming events
04 NOV
Earnings
Upcoming earnings report